bullish charts that are focused on long term growth and are not affected by earnings reports inverted head and shoulders
## source: finance.yahoo.com
Tue, 28 Jul 2015 21:06:05 GMT ~ Oragenics Reports Positive In Vivo Antibiotic Efficacy Data in Critical Animal Study
[at noodls] - TAMPA, Fla. & GERMANTOWN, Md.--(BUSINESS WIRE)--Jul. 28, 2015-- Oragenics, Inc. (NYSE MKT: OGEN) and Intrexon Corporation (NYSE:XON), a leader in synthetic biology, announced today positive data on multiple ...
Tue, 28 Jul 2015 20:05:00 GMT ~ Oragenics Reports Positive In Vivo Antibiotic Efficacy Data in Critical Animal Study
[Business Wire] - Oragenics, Inc. and Intrexon Corporation , a leader in synthetic biology, announced today positive data on multiple compounds from Oragenics’ Mutacin 1140 lantibiotic platform in a critical animal model study, as well as the selection of a lead clinical candidate.
Link: http://www.otcmarkets.com/stock/OGEN/company-info Ticker: $OGEN OTC Market Place: Not Available CIK code: 0001174940 Company name: Oragenics, Inc. Company website: http://www.oragenics.com Incorporated In: FL, USA
Business Description:
$OGEN share structure
## source: otcmarkets.com
Market Value: $63,299,363 a/o Jul 28, 2015 Shares Outstanding: 36,378,944 a/o May 08, 2015 Float: Not Available Authorized Shares: Not Available Par Value: 0.001
$OGEN extra dd links
Company name: Oragenics, Inc. Company website: http://www.oragenics.com